GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Natus Medical Incorporated (BABY) [hlAlert]

Rating:
Mkt Outperform
BABY
up 123.39 %

Natus Medical Incorporated (BABY) upgraded to Mkt Outperform with price target $22 by Avondale Partners

Posted on: Tuesday,  Feb 12, 2008  12:25 PM ET by Avondale Partners

Avondale Partners rated Mkt Outperform Natus Medical Incorporated (NASDAQ: BABY) on 02/12/2008, when the stock price was $18.51.
Since then, Natus Medical Incorporated has gained 123.39% as of 01/12/2016's recent price of $41.35.
If you would have followed this Avondale Partners's recommendation on BABY, you would have gained 123.39% of your investment in 2891 days.

Natus Medical Incorporated is a leading provider of healthcare products used for the screening, detection, treatment, monitoring and tracking of common medical ailments such as hearing impairment, neurological dysfunction, epilepsy, sleep disorders, and newborn care. Product offerings include computerized neurodiagnostic systems for audiology, neurology, polysomnography, and neonatology, as well as newborn care products such as hearing screening systems, phototherapy devices for the treatment of newborn jaundice, head-cooling products for the treatment of brain injury in newborns, and software systems for managing and tracking disorders and diseases for public health laboratories.

Avondale’s research analysts are charged with producing high quality, independent, value-added, and timely investment analysis / advice. The firm’s strategy is to deemphasize maintenance research, and instead direct the overwhelming majority of our efforts on developing well-constructed, actionable recommendations, in part by leveraging proprietary networks of industry contacts. Avondale’s growing research department now totals 25 professionals. Senior analysts average 14 years of industry experience and are routinely recognized by a variety of nationally known rating entities. In the last two years, Avondale Analysts were named to the Wall Street Journal’s Best on the Street poll as well as Forbes.com’s Top Analyst Rankings.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
2/12/2008 12:25 PM Buy
None
18.51 22.00
as of 12/24/2008
1 Week down  -6.51 %
1 Month down  -5.30 %
3 Months up  8.20 %
1 YTD down  -37.91 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
2/1/2008 10:25 AM Hold
None
17.40 20.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy